ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1073

B Cell Subsets Are Epigenetically and Transcriptionally Dysregulated in Systemic Lupus Erythematosus

Emily Blalock1, Chris Scharer2, Ben Barwick2, Scott Jenks3, Bridget Neary3, Jeremy Boss2 and Ignacio Sanz3,4, 1Emory University School of Medicine, Atlanta, GA, 2Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, 3Rheumatology, Emory University School of Medicine, Atlanta, GA, 4Medicine, Emory University, Atlanta, GA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: B cells, SLE and epigenetics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Genetics, Gene Expression, and Epigenetics

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by multiple B cell abnormalities, including the production of autoantibodies, a major contributing factor to disease pathogenesis. Epigenetic modifications that drive the early molecular events leading to the activation of autoreactive B cells in SLE remain unclear. Therefore, we investigated the epigenetic and transcriptional signatures of SLE B cell subsets including activated naïve (aN), resting naïve (rN), late transitional (T3), switched memory (SM), and double negative (DN) B cells.

Methods: We simultaneously profiled the methylome and transcriptome of B cell subsets from SLE and healthy control (HC) African American females utilizing reduced representation bisulfite sequencing (RRBS) and RNA-seq, respectively. In addition, chromatin accessibility in SLE and HC B cells subsets was determined using assay for transposase-accessible chromatin (ATAC)-seq.

Results: Global DNA methylation analysis of total B cells identified 2,686 SLE-disease specific differentially methylated loci surrounding 951 genes. Demethylated genes in SLE B cells included IFN response genes as well as negative regulators of the viral response, while cell-cell signaling and calcium transmembrane transport genes were methylated. SLE and HC aN B cells gained DNA methylation at 2,952 loci and lost DNA methylation at 82,313 loci when compared compared to rN B cells, indicating a loss of DNA methylation during the transition from a rN to an aN B cell state. Transcriptome analysis of total B cells identified 334 differentially regulated genes in SLE patients. In individual B cell subsets, 953 genes were differentially regulated between B cell types; these cell-type transciptomes diverged from one another as cells differentiated from rN to aN to DN B cells. Integrated analysis of the methylome and transcriptome data sets identified 85 genes, 35 of which were IFN-regulated genes, whose DNA methylation changes inversely correlated with SLE disease-specific changes in gene expression.

Conclusion: DNA methylation analysis indicated the largest differences between cell types with aN B cells undergoing a genome-wide hypomethylation. Transcriptionally aN and rN B cells are more similar to each other, whereas DN B cells are more disparate. This could reflect the cell stage of activation/differentiation, as we hypothesize that differentiation occurs in a linear manner from rN to aN to DN B cells. Although the largest differences were observed between B cell types, there were consistent SLE-specific gene expression differences (i.e.: IFN). Our results indicate that SLE B cells are epigenetically and transcriptionally distinct from HC B cells, suggesting that SLE B cells may be pathogenically programmed at an early stage of maturation.


Disclosure: E. Blalock, None; C. Scharer, None; B. Barwick, None; S. Jenks, None; B. Neary, None; J. Boss, None; I. Sanz, None.

To cite this abstract in AMA style:

Blalock E, Scharer C, Barwick B, Jenks S, Neary B, Boss J, Sanz I. B Cell Subsets Are Epigenetically and Transcriptionally Dysregulated in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/b-cell-subsets-are-epigenetically-and-transcriptionally-dysregulated-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-subsets-are-epigenetically-and-transcriptionally-dysregulated-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology